Your search returned 5483 results.

Results
	3321.	miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation. [electronic resource] by Xu, JianFeng Huang, ZheYong Lin, Li Fu, MingQiang Gao, YanHua Shen, YunLi Zou, YunZeng Sun, AiJun Qian, JuYing Ge, JunBo Producer: 20150703 In: Science China. Life sciences vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3322.	CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation. [electronic resource] by Suda, Kenichi Mizuuchi, Hiroshi Murakami, Isao Uramoto, Hidetaka Tanaka, Fumihiro Sato, Katsuaki Takemoto, Toshiki Iwasaki, Takuya Sekido, Yoshitaka Yatabe, Yasushi Mitsudomi, Tetsuya Producer: 20150709 In: Lung cancer (Amsterdam, Netherlands) vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3323.	Cordycepin inhibits renal interstitial myofibroblast activation probably by inducing hepatocyte growth factor expression. [electronic resource] by Li, Li He, Dongyuan Yang, Junwei Wang, Xiaoyun Producer: 20120424 In: Journal of pharmacological sciences vol. 117 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3324.	Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. [electronic resource] by Kwiecinski, Monika Noetel, Andrea Elfimova, Natalia Trebicka, Jonel Schievenbusch, Stephanie Strack, Ingo Molnar, Levente von Brandenstein, Melanie Töx, Ulrich Nischt, Roswitha Coutelle, Oliver Dienes, Hans Peter Odenthal, Margarete Producer: 20120608 In: PloS one vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3325.	A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111). [electronic resource] by Geller, James I Perentesis, John P Liu, Xiaowei Minard, Charles G Kudgus, Rachel A Reid, Joel M Fox, Elizabeth Blaney, Susan M Weigel, Brenda J Producer: 20171025 In: Pediatric blood & cancer vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3326.	First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours. [electronic resource] by Rodon, Jordi Postel-Vinay, Sophie Hollebecque, Antoine Nuciforo, Paolo Azaro, Analia Cattan, Valérie Marfai, Lucie Sudey, Isabelle Brendel, Karl Delmas, Audrey Malasse, Stéphanie Soria, Jean-Charles Producer: 20170825 In: European journal of cancer (Oxford, England : 1990) vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3327.	Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer. [electronic resource] by Kim, Jae-Young Welsh, Eric A Fang, Bin Bai, Yun Kinose, Fumi Eschrich, Steven A Koomen, John M Haura, Eric B Producer: 20170731 In: Molecular cancer research : MCR vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3328.	(1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies. [electronic resource] by Ebrahim, Hassan Y Mohyeldin, Mohamed M Hailat, Mohammad M El Sayed, Khalid A Producer: 20170814 In: Bioorganic & medicinal chemistry vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3329.	Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma. [electronic resource] by Cheng, Hanyin Terai, Mizue Kageyama, Ken Ozaki, Shinji McCue, Peter A Sato, Takami Aplin, Andrew E Producer: 20150930 In: Cancer research vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3330.	Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase. [electronic resource] by Liu, Yang Jin, Shiyu Peng, Xia Lu, Dong Zeng, Limin Sun, Yiming Ai, Jing Geng, Meiyu Hu, Youhong Producer: 20161011 In: European journal of medicinal chemistry vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3331.	MET amplification, protein expression, and mutations in pulmonary adenocarcinoma. [electronic resource] by Park, Seongyeol Koh, Jaemoon Kim, Dong-Wan Kim, Miso Keam, Bhumsuk Kim, Tae Min Jeon, Yoon Kyung Chung, Doo Hyun Heo, Dae Seog Producer: 20161013 In: Lung cancer (Amsterdam, Netherlands) vol. 90 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3332.	Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses. [electronic resource] by van Veggel, Bianca de Langen, Adrianus J Hashemi, Sayed Monkhorst, Kim Rosenberg, Efraim H Heideman, Daniëlle A M Radonic, Teodora Smit, Egbert F Producer: 20190912 In: Lung cancer (Amsterdam, Netherlands) vol. 124 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3333.	Hepatocyte growth factor promotes the proliferation of human embryonic stem cell derived retinal pigment epithelial cells. [electronic resource] by Karamali, Fereshteh Esfahani, Mohammad-Hossein Nasr Hajian, Mehdi Ejeian, Fatemeh Satarian, Leila Baharvand, Hossein Producer: 20200316 In: Journal of cellular physiology vol. 234 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3334.	MicroRNA‑200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c‑Met signaling pathway. [electronic resource] by Du, Menghua Wang, Jin Chen, Huan Wang, Shouli Chen, Liesong Xu, Yichang Su, Fengtao Lu, Xueguan Producer: 20190305 In: Oncology reports vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3335.	Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study. [electronic resource] by Wang, Wenxian Wang, Hong Lu, Peihua Yu, Zongyang Xu, Chunwei Zhuang, Wu Song, Zhengbo Producer: 20200401 In: Journal of translational medicine vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3336.	INC280 inhibits Wnt/β-catenin and EMT signaling pathways and its induce apoptosis in diffuse gastric cancer positive for c-MET amplification. [electronic resource] by Sohn, Sung-Hwa Kim, Bohyun Sul, Hee Jung Kim, Yoo Jin Kim, Hyeong Su Kim, Hongtae Seo, Jong Bok Koh, Youngho Zang, Dae Young Producer: 20190708 In: BMC research notes vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3337.	Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status. [electronic resource] by Das, Ishani Wilhelm, Margareta Höiom, Veronica Franco Marquez, Rodolfo Costa Svedman, Fernanda Hansson, Johan Tuominen, Rainer Egyhàzi Brage, Suzanne Producer: 20200730 In: Cell death & disease vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3338.	Development of c‑MET‑specific chimeric antigen receptor‑engineered natural killer cells with cytotoxic effects on human liver cancer HepG2 cells. [electronic resource] by Liu, Bing Liu, Zheng-Zhi Zhou, Mei-Ling Lin, Jian-Wei Chen, Xue-Mei Li, Zhu Gao, Wen-Bin Yu, Zhen-Dong Liu, Tao Producer: 20200204 In: Molecular medicine reports vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3339.	In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for c-Met Inhibitor MET401. [electronic resource] by Zhang, Jiang Wei Deng, Hai Bing Zhang, Chun Ye Dai, Jing Quan Li, Qian Zheng, Qian Gang Wan, Hui Xin Yu, Hong Ping He, Feng Xu, Yao Chang Zhao, Sylvia Zhang, Ji Yue Jeff Producer: 20200205 In: European journal of drug metabolism and pharmacokinetics vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3340.	Synthesis and biological evaluation of new MET inhibitors with 1,6-naphthyridinone scaffold. [electronic resource] by Wang, Ming-Shu Zhuo, Lin-Sheng Yang, Fan-Peng Wang, Wen-Jie Huang, Wei Yang, Guang-Fu Producer: 20200218 In: European journal of medicinal chemistry vol. 185 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 5483 results.